ICD10 code of 22q11 DiGeorge Syndrome and ICD9 code

22q11.2 deletion syndrome, commonly known as 22q11 DiGeorge syndrome, is primarily classified under ICD-10 code Q93.81 (Velo-cardio-facial syndrome) or Q93.5 (other chromosome deletions). In the ICD-9 coding system, this condition was historically classified under 758.32 (Velo-cardio-facial syndrome) or 758.31 (DiGeorge syndrome).

What is the clinical significance of the 22q11 DiGeorge syndrome classification?

While ICD codes are essential for billing, insurance authorization, and hospital data collection, they are simply administrative tools for identifying 22q11 DiGeorge syndrome in medical records. Because 22q11 DiGeorge syndrome presents with a highly variable phenotype—ranging from cardiac defects and immune deficiencies to learning disabilities and psychiatric challenges—clinicians often use multiple codes to capture the full clinical picture. Understanding the transition from ICD-9 to ICD-10 is vital for patients when requesting medical records or coordinating care across different healthcare systems, as the specificity of the 22q11 DiGeorge syndrome diagnosis has improved with the adoption of more precise coding standards.

How is 22q11 DiGeorge syndrome diagnosed?

The definitive diagnosis of 22q11 DiGeorge syndrome is made through genetic testing, typically using a chromosomal microarray (CMA) or fluorescence in situ hybridization (FISH) to detect the microdeletion on the long arm of chromosome 22. Because 22q11 DiGeorge syndrome can affect many organ systems, diagnosis often involves a multidisciplinary team. At DiseaseMaps.org, 215 people with 22q11 DiGeorge syndrome have shared their experiences, highlighting the importance of early genetic confirmation to guide specialized care.

What are the common features associated with 22q11 DiGeorge syndrome?

The clinical presentation of 22q11 DiGeorge syndrome is diverse, and no two individuals share the exact same symptom profile. Common clinical features that may be coded alongside the primary diagnosis include:

• Congenital heart defects (such as Tetralogy of Fallot or interrupted aortic arch)


• Palatal abnormalities (such as cleft palate or velopharyngeal insufficiency)


• Hypocalcemia due to hypoparathyroidism


• Immune system dysfunction resulting from thymic hypoplasia


• Developmental delays and specific learning disabilities


• Increased risk for psychiatric conditions later in life, including anxiety and schizophrenia

Is 22q11 DiGeorge syndrome hereditary?

In approximately 90% of cases, 22q11 DiGeorge syndrome occurs as a "de novo" mutation, meaning it is not inherited from either parent. However, in about 10% of cases, the deletion is passed from a parent to a child. Genetic counseling is strongly recommended for families affected by 22q11 DiGeorge syndrome to assess recurrence risks and provide support for family planning.

Next steps

• Consult with a clinical geneticist to review your specific diagnostic report and ensure the correct clinical codes are being used in your medical file.


• Connect with the community of 215 members at DiseaseMaps.org to share experiences and find peer support.


• Maintain a consolidated "medical passport" that lists your genetic test results, current ICD-10 codes, and a summary of your specialists to facilitate seamless care coordination.


• Reach out to the International 22q11.2 Foundation for resources on clinical management and regional support groups.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: 22q11.2 deletion syndrome.


• Orphanet: 22q11.2 deletion syndrome (ORPHA:96156).


• OMIM (Online Mendelian Inheritance in Man): 22q11.2 Deletion Syndrome (Entry #188400).


• The International 22q11.2 Foundation: Clinical care guidelines and patient resources.